A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man.
A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man. Thromb Haemost. 1990 Nov 30; 64(3):369-73.